Liver dialysis for severe acute-on-chronic liver failure
Part of Digestive system clinical trials.
This trial tests a new liver dialysis device called DIALIVE 2.0 for people with acute-on-chronic liver failure (a sudden, severe worsening of chronic liver disease). If you qualify, the device will help filter your blood, similar to kidney dialysis, to support your liver while it tries to recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old
- You have been diagnosed with acute-on-chronic liver failure (a sudden worsening of chronic liver disease) that is severe (grade 2 to 4) and started within the last 10 days
- Your liver failure has not improved with standard care in the first 48 hours
- You cannot be pregnant or have had a liver transplant
- You shouldn't have serious infections, uncontrolled bleeding, or other major health problems that would make this trial unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure that filters harmful substances from your blood using a special machine. It is for people with severe liver failure (acute-on-chronic) who have signs of inflammation throughout the body.
This trial tests whether removing and replacing blood plasma (a blood-cleaning procedure) can help people with sudden, severe liver failure recover. The treatment aims to support the liver while it heals or while waiting for a transplant.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
This trial tests a device that uses a specially pig liver to help people with severe, sudden liver failure who cannot get a transplant. It aims to support the liver until it recovers or a transplant becomes possible.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This trial is testing new scoring systems to better predict how patients with acute-on-chronic liver failure will do. It may help doctors make more informed treatment decisions for people with this serious liver condition.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.